Binnopharm Group, a pharmaceutical company, announces its unaudited consolidated IFRS financial results for the first half ended 30 June 2022.
In 1H 2022, the Company’s revenue increased by 16.3% year-on-year to RUB 12.6 bn, with OIBDA up 32% year-on-year to hit RUB 3.4 bn.
The strong financial performance was primarily due to higher revenue from retail and export sales. Retail revenue saw a 32% year-on-year growth, with brands like Kipferon, Urdoxa, Angiorus, Diclofenac and Elmucin as the key contributors. Sales of venotonic Angiorus and non-steroidal anti-inflammatory drug Diclofenac in money terms surged by 50% and 41% year-on-year, respectively, while revenue from immunomodulator Kipferon almost doubled.
[expert_review params=”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”]In 1H 2022, the Company’s export revenue soared by 150% mainly driven by the opening of official representative offices in six CIS countries and the launch of aggressive promotion for the Group’s flagship branded products in the region.
